Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Thermo Fisher Scientific Ranked Leading Vendor in Infrared Spectroscopy

By Drug Discovery Trends Editor | August 13, 2008

Thermo Fisher Scientific Inc. received the highest overall vendor rating for infrared (IR) spectroscopy instrumentation according to the Worldwide Molecular Spectroscopy Survey published by Strategic Directions International (SDi) Inc in July 2008. The primary factors for selection of an IR vendor include performance, service, instrument specifications and vendor experience. The Thermo Fisher Scientific IR spectroscopy portfolio was clearly rated the highest among survey respondents in virtually all of the categories, with the most outstanding score being for instrument quality.

The report was compiled through end-user internet surveys covering an extended array of industries including academia, pharmaceuticals, chemicals, CROs, plastics/polymers, biotechnology, consumer products and petrochemicals. Survey responses were collected in April and May 2008 and a total of 525 questionnaires were returned with detailed answers to the inquiries.

The SDi survey results stated that “more than half of the most recently purchased IR instruments were from Thermo Fisher Scientific, which is consistent with the company’s leadership in the IR spectroscopy market.”  It was further reported that the Thermo Scientific IR spectroscopy product portfolio is perceived as the highest quality offering available on the market.

“We are extremely pleased to have had our commitment to developing cutting edge IR instrumentation recognized by the findings of this study”, comments Mike Jost, vice president & GM, molecular spectroscopy and microanalysis, Thermo Fisher Scientific. “Thermo Fisher is at the forefront of development and we are constantly looking at ways to improve our offerings. This is clearly demonstrated by the development of our new software capabilities, for example OMNIC Picta and Specta. These products provide the most advanced level of integration between software, spectrometer and sampling accessory of any vibrational software package on the market. These developments respond directly to market needs.”

Release date: August 12, 2008
Source: Thermo Fisher Scientific


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE